44.02MMarket Cap-10081P/E (TTM)
0.000High0.000Low0Volume0.000Open4.940Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)8.91MShares5.59052wk High1.67P/B28.61MFloat Cap3.34052wk Low--Dividend TTM5.79MShs Float13.200Historical High--Div YieldTTM0.00%Amplitude1.000Historical Low--Avg Price1Lot Size
ImmuCell Stock Forum
ImmuCell Corporation (Nasdaq: ICCC), a key player in the animal health industry, has recently announced its preliminary, unaudited sales results for the first quarter of 2024, and the figures are nothing short of impressive. With a staggering 111% increase in sales compared to the same period in 2023, and a 42% increase from the last quarter of ...
No comment yet